Fund Holdings — ACORN CAPITAL ADVISORS, LLC

Total Portfolio Value
$366.46M
Total Bought
$33.36M
Total Sold
$103.34M
Net Transaction
-$69.98M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
UROGEN PHARMA LTD(URGN)1,673,4201,673,420030,08861,58216.80%+31,494
CANDEL THERAPEUTICS INC(CADL)3,497,9483,497,948017,21036,0299.83%+18,819
TREVI THERAPEUTICS INC(TRVI)2,144,8442,144,844025,58840,00110.92%+14,413
KARYOPHARM THERAPEUTICS INC(KPTI)287,8261,518,113+1,230,2871,60314,8324.05%+13,229
JADE BIOSCEINCES INC786,760986,760+200,00011,05421,9265.98%+10,872
PUMA BIOTECHNOLOGY INC(PBYI)4,131,2994,131,299026,39933,5059.14%+7,106
BICARA THERAPEUTICS643,382643,381-112,79719,1025.21%+6,305
CG ONCOLOGY INC(CGON)1,130,5011,131,500+99976,58080,39321.94%+3,813
HELUS PHARMA INC.(HELP)1,540,2661,540,26607,39310,1812.78%+2,788
AURA BIOSCIENCES INC(AURA)595,744929,077+333,3333,9866,5961.80%+2,611
EUGENE THERAPEUTICS(ENGN)01,271,257+1,271,25702,1990.60%+2,199
WHITEHAWK THERAPEUTICS INC(WHWK)1,139,3631,139,36303,9315,2181.42%+1,287
ONKURE THERAPEUTICS INC(OKUR)2,839,6742,839,674011,75612,9493.53%+1,193
Q32 BIO INC.(FIXX)315,052216,171-98,8812,0232,7540.75%+731
VYNE THERAPEUTICS INC(YARW)1,4251,4250110.00%0
BIOATLA INC(BCAB)5,406,345108,126-5,298,2198654480.12%-417
JASPER THERAPEUTICS(JSPR)1,411,4921,438,159+26,6671,2426040.16%-638
LEONABIO, INC.(LONA)634,539634,53906,5235,8311.59%-692
X4 PHARMACEUTICALS INC(XFOR)234,0390-234,0399670—-967
VERASTEM INC(VSTM)1,469,1531,469,15307,7875,6121.53%-2,174
PROTARA THERAPEUTICS INC(TARA)1,752,1151,752,11509,1296,6931.83%-2,435
CARDIF ONCOLOGY INC(CRDF)1,762,0840-1,762,0842,8550—-2,855
TERNS PHARMACEUTICALS INC1,746,2640-1,746,26492,0630—-92,063
Page 1 of 1